As it is only so far known to be generally upregulated in CRC and its metastases (41, 64), it is surprising that in our study EpCAM yielded the second highest fold change in CRLM-SD LM in comparison to the other LM subgroups. The gene discussed is EPCAM; the disease is colorectal carcinoma.